Clinical trial

Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in…

NCT00148213 · University Hospital Muenster, Other · Completed

Key facts

NCT number NCT00148213
Title Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
Official title Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
Lead sponsor University Hospital Muenster, Other
Collaborators Nichols Institute Diagnostika GmbH, Bad Vilbel, Germany
Status Completed
Study type Observational
Conditions Thyroid Neoplasms
Enrollment 100
Start date Sep 1, 2003
Completion Jun 1, 2005
First posted Sep 7, 2005
Last update posted Sep 7, 2005
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies